These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15032178

  • 1. T-1249 development hits a snag.
    AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032178
    [No Abstract] [Full Text] [Related]

  • 2. On approval.
    Huff B.
    GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
    [No Abstract] [Full Text] [Related]

  • 3. New fixed dose once-a-day combinations. Interview by John S. James.
    Cohen C.
    IAPAC Mon; 2004 Nov; 10(11):414-5, 432. PubMed ID: 15744891
    [No Abstract] [Full Text] [Related]

  • 4. An overview of the drug approval process.
    Martinez LJ.
    Res Initiat Treat Action; 2002 Nov; 8(1):11-7. PubMed ID: 12489521
    [No Abstract] [Full Text] [Related]

  • 5. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract] [Full Text] [Related]

  • 6. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
    AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
    [No Abstract] [Full Text] [Related]

  • 7. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
    AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
    [No Abstract] [Full Text] [Related]

  • 8. 100th HIV/AIDS antiretroviral drug approved by PEPFAR.
    AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372
    [No Abstract] [Full Text] [Related]

  • 9. Experimental drug quickly suppresses HIV.
    AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233
    [No Abstract] [Full Text] [Related]

  • 10. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract] [Full Text] [Related]

  • 11. Emerging drugs in the fight against HIV disease.
    Rosenthal E.
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract] [Full Text] [Related]

  • 12. FDA gives salvage therapy testing a push forward.
    Bass E.
    AIDS Treat News; 2001 Mar 23; (362):3-7, 1. PubMed ID: 11569956
    [Abstract] [Full Text] [Related]

  • 13. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp.
    Kessler H.
    Posit Aware; 2007 Mar 23; 18(6):22-4. PubMed ID: 18074429
    [No Abstract] [Full Text] [Related]

  • 14. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
    AIDS Alert; 2008 Apr 23; 23(4):46-7. PubMed ID: 19255980
    [No Abstract] [Full Text] [Related]

  • 15. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May 23; 23(5):396-7. PubMed ID: 19422067
    [No Abstract] [Full Text] [Related]

  • 16. T-20 (Fuzeon) gets priority review.
    AIDS Treat News; 2002 Oct 18; (384):4-5. PubMed ID: 12434762
    [No Abstract] [Full Text] [Related]

  • 17. FDA notifications. Tentative approval granted for combo antiretroviral drug.
    AIDS Alert; 2007 Oct 18; 22(10):117-8. PubMed ID: 18416009
    [No Abstract] [Full Text] [Related]

  • 18. FDA notifications. Changes to ART guidelines detailed by the FDA.
    AIDS Alert; 2008 Mar 18; 23(3):33-4. PubMed ID: 18663777
    [No Abstract] [Full Text] [Related]

  • 19. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
    Cohen J.
    Science; 2004 Oct 08; 306(5694):213. PubMed ID: 15472049
    [No Abstract] [Full Text] [Related]

  • 20. Long path to approval. A look back at the road to Fuzeon.
    GMHC Treat Issues; 2003 Mar 08; 17(3):1-5. PubMed ID: 12728856
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.